Kevin Messacar1,2, Amanda L Hurst3, Jason Child3, Kristen Campbell4, Claire Palmer5, Stacey Hamilton6, Elaine Dowell6, Christine C Robinson6, Sarah K Parker1, Samuel R Dominguez1,7. 1. Department of Pediatrics, Section of Infectious Diseases. 2. Department of Pediatrics, Section of Hospital Medicine, University of Colorado/Children's Hospital. 3. Pharmacy. 4. Department of Biostatistics and Informatics, University of Colorado School of Public Health. 5. Department of Pediatrics, University of Colorado. 6. Department of Pathology and Laboratory Medicine. 7. Department of Epidemiology, Children's Hospital Colorado, Aurora.
Abstract
BACKGROUND: Rapid diagnostic technologies for infectious diseases have the potential to improve clinical outcomes, but guideline-recommended antimicrobial stewardship (AS) strategies are not currently optimized for rapid intervention. We evaluated the clinical impact and provider acceptability of implementing real-time AS decision support for children with positive blood culture results according to the FilmArray blood culture identification panel (BCID [BioFire Diagnostics]) at Children's Hospital Colorado. METHODS: A pre-post quasi-experimental design was used to compare the outcomes of 100 postintervention children with positive blood culture results matched with 200 preintervention control children. Causative organisms in the preintervention group were identified using conventional microbiologic techniques and communicated to providers by a microbiology technologist. Postintervention organisms were identified by the BCID and communicated by an AS provider in real time with interpretation and antimicrobial recommendations. The primary outcome was time to optimal antimicrobial therapy (time from blood culture collection to start of predetermined pathogen-specific regimen or antimicrobial discontinuation for contaminants) compared by a log-rank test and Kaplan-Meier analysis. Provider acceptability of the intervention was assessed via E-mailed surveys. RESULTS: The median time to optimal therapy decreased from 60.2 hours before intervention to 26.7 hours after intervention (P = .001). Among children with blood cultures that contained true pathogens, the time to effective antimicrobial therapy decreased from 6.9 to 3.4 hours (P = .03). Unnecessary antibiotic initiation for children with a culture that contained organisms considered to be contaminants decreased from 76% to 26% (P < .001). Providers reported a change in management as a result of BCID results in 73% of the cases and a mean overall satisfaction rating of 4.8 on a 5-point Likert scale. CONCLUSIONS: Real-time AS decision support for rapid diagnostics is associated with improved antimicrobial use and high satisfaction ratings by providers.
BACKGROUND: Rapid diagnostic technologies for infectious diseases have the potential to improve clinical outcomes, but guideline-recommended antimicrobial stewardship (AS) strategies are not currently optimized for rapid intervention. We evaluated the clinical impact and provider acceptability of implementing real-time AS decision support for children with positive blood culture results according to the FilmArray blood culture identification panel (BCID [BioFire Diagnostics]) at Children's Hospital Colorado. METHODS: A pre-post quasi-experimental design was used to compare the outcomes of 100 postintervention children with positive blood culture results matched with 200 preintervention control children. Causative organisms in the preintervention group were identified using conventional microbiologic techniques and communicated to providers by a microbiology technologist. Postintervention organisms were identified by the BCID and communicated by an AS provider in real time with interpretation and antimicrobial recommendations. The primary outcome was time to optimal antimicrobial therapy (time from blood culture collection to start of predetermined pathogen-specific regimen or antimicrobial discontinuation for contaminants) compared by a log-rank test and Kaplan-Meier analysis. Provider acceptability of the intervention was assessed via E-mailed surveys. RESULTS: The median time to optimal therapy decreased from 60.2 hours before intervention to 26.7 hours after intervention (P = .001). Among children with blood cultures that contained true pathogens, the time to effective antimicrobial therapy decreased from 6.9 to 3.4 hours (P = .03). Unnecessary antibiotic initiation for children with a culture that contained organisms considered to be contaminants decreased from 76% to 26% (P < .001). Providers reported a change in management as a result of BCID results in 73% of the cases and a mean overall satisfaction rating of 4.8 on a 5-point Likert scale. CONCLUSIONS: Real-time AS decision support for rapid diagnostics is associated with improved antimicrobial use and high satisfaction ratings by providers.
Authors: Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton Journal: Clin Infect Dis Date: 2006-12-13 Impact factor: 9.079
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi Journal: Clin Infect Dis Date: 2016-04-13 Impact factor: 9.079
Authors: R Scott Watson; Joseph A Carcillo; Walter T Linde-Zwirble; Gilles Clermont; Jeffrey Lidicker; Derek C Angus Journal: Am J Respir Crit Care Med Date: 2002-11-14 Impact factor: 21.405
Authors: Jason G Newland; Leslie M Stach; Stephen A De Lurgio; Erin Hedican; Diana Yu; Joshua C Herigon; Priya A Prasad; Mary Anne Jackson; Angela L Myers; Theoklis E Zaoutis Journal: J Pediatric Infect Dis Soc Date: 2012-07-12 Impact factor: 3.164
Authors: Ashley M Lockwood; Katherine K Perez; William L Musick; Judy O Ikwuagwu; Engie Attia; Oyejoke O Fasoranti; Patricia L Cernoch; Randall J Olsen; James M Musser Journal: Infect Control Hosp Epidemiol Date: 2016-01-07 Impact factor: 3.254
Authors: Katherine K Perez; Randall J Olsen; William L Musick; Patricia L Cernoch; James R Davis; Geoffrey A Land; Leif E Peterson; James M Musser Journal: Arch Pathol Lab Med Date: 2012-12-06 Impact factor: 5.534
Authors: Joe Pardo; Kenneth P Klinker; Samuel J Borgert; Brittany M Butler; Patricia G Giglio; Kenneth H Rand Journal: Diagn Microbiol Infect Dis Date: 2015-11-11 Impact factor: 2.803
Authors: P B Bookstaver; E B Nimmich; T J Smith; J A Justo; J Kohn; K L Hammer; C Troficanto; H A Albrecht; M N Al-Hasan Journal: Antimicrob Agents Chemother Date: 2017-08-24 Impact factor: 5.191
Authors: Poornima Ramanan; Alexandra L Bryson; Matthew J Binnicker; Bobbi S Pritt; Robin Patel Journal: Clin Microbiol Rev Date: 2017-11-15 Impact factor: 26.132
Authors: Gary V Doern; Karen C Carroll; Daniel J Diekema; Kevin W Garey; Mark E Rupp; Melvin P Weinstein; Daniel J Sexton Journal: Clin Microbiol Rev Date: 2019-10-30 Impact factor: 26.132
Authors: Angela Fimbres Veesenmeyer; Jared A Olson; Adam L Hersh; Chris Stockmann; Kent Korgenski; Emily A Thorell; Andrew T Pavia; Anne J Blaschke Journal: Infect Dis Ther Date: 2016-11-10
Authors: Preeti Pancholi; Karen C Carroll; Donna M Wolk; Blake W Buchan; Raymond C Chan; Neelam Dhiman; Bradley Ford; Paul A Granato; Amanda T Harrington; Diana R Hernandez; Romney M Humphries; Matthew R Jindra; Nathan A Ledeboer; Shelley A Miller; A Brian Mochon; Margie A Morgan; Robin Patel; Paul C Schreckenberger; Paul D Stamper; Patricia J Simner; Nancy E Tucci; Cynthia Zimmerman Journal: J Clin Microbiol Date: 2018-03-26 Impact factor: 5.948